Food News and Research

RSS

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced that the U.S. Food and Drug Administration granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency, also known as Wolman disease.

20 May 2013

GE Healthcare initiates global public awareness campaign on cancer prevention

GE Healthcare has today launched its third annual #GetFit global public awareness campaign on cancer prevention. This year's campaign leverages social media channels including Instagram, Sina Weibo in China, and Twitter to enable participation, interaction and engagement.

20 May 2013

Promising method to distinguish pancreatic cancer from chronic pancreatitis

Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis - two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic "juices" can identify almost all cases of pancreatic cancer, their study shows.

20 May 2013

More objective testing may reduce cost and risk of managing GERD, study suggests

There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week.

20 May 2013

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking vortioxetine, an investigational agent under review with the U.S. Food and Drug Administration for the treatment of major depressive disorder.

20 May 2013

All sterile drug products from NuVision Pharmacy lack sterility assurance, FDA warns

The U.S. Food and Drug Administration is alerting health care providers of concerns about a lack of sterility assurance of all sterile drug products made and distributed by NuVision Pharmacy of Dallas, Texas.

20 May 2013

Wheat Initiative: 60% increase in wheat production needed by 2050

By 2050, a 60% increase in wheat production will be needed to meet the demand of a growing population. The Wheat Initiative, an international consortium gathering public institutions and private companies, was created as part of the 2011 action plan of the G20 Agricultural Ministries to coordinate global wheat research and participate to global food security.

18 May 2013

MGM Resorts International receives 2013 Truven Health Advantage Award for Overall Performance

Mike Boswood, president and CEO of Truven Health Analytics presented the 2013 Truven Health Advantage Award for Overall Performance to MGM Resorts International, a global leader in hospitality.

18 May 2013

Parents need to protect children from allergen exposure, says Hope Paige CEO

A report released earlier this month by the Centers for Disease Control and Prevention calls allergy rates among U.S. children an "epidemic."

18 May 2013

Atlanta residents to celebrate science festival in March 2014

Atlanta residents of all ages will celebrate the science and technology of the region and its impact on our daily lives during the inaugural Atlanta Science Festival, March 22-29, 2014.

18 May 2013

Journal of Caffeine Research: FDA needs to be vigilant, proactive in regulating caffeine

Caffeine is being added to a growing number of food and drink products, including energy drinks, snack foods, and even gum, that are often marketed to adolescents and children.

18 May 2013

FDA to review QRxPharma's resubmitted MOXDUO NDA in July 2013

QRxPharma Limited announced today the US Food and Drug Administration has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO New Drug Application.

18 May 2013

FDA seeks injunction in court against New York City Fish

The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, is seeking a preliminary injunction in the U.S. District Court for the Eastern District of New York against New York City Fish, Inc., and several key employees for manufacturing and distributing ready-to-eat fish products under insanitary conditions causing them to become adulterated.

18 May 2013

New LAMP malaria test to improve diagnosis for imported UK cases

A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to new research published in the Journal of Infectious Diseases.

17 May 2013

FDA approves Mylan's ANDA for Fenofibrate Tablets

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg.

17 May 2013

FDA clears Oramed Pharmaceuticals' IND for ORMD-0801

Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that the United States Food and Drug Administration has cleared the Company's Investigational New Drug application for ORMD-0801, its oral insulin capsule.

17 May 2013

IFT announces new partnership to bring CFS certification to CIFST members

The Institute of Food Technologists today announced a new partnership with the Canadian Institute of Food Science and Technology that brings the Certified Food Scientist certification to CIFST members.

17 May 2013

Study evaluates effects menu labeling in restaurant meals

Menu labeling has made more people aware of how many calories are in restaurant meals and has some people reducing their intake, according to new research published in the American Journal of Preventive Medicine.

17 May 2013

Viewpoints: When a doctor should keep quiet; 2 views of hospital pricing; Stem cell 'snake oil'

In medical school, we were taught not to withhold information from our patients or to be "paternal" in making decisions for them. We internalized the idea that fully informed patients are better equipped to make treatment decisions.

17 May 2013

Protein processing breakdown in endoplasmic reticulum

With obesity reaching epidemic levels in some parts of the world, scientists have only begun to understand why it is such a persistent condition. A study in the Journal of Biological Chemistry adds substantially to the story by reporting the discovery of a molecular chain of events in the brains of obese rats that undermined their ability to suppress appetite and to increase calorie burning.

17 May 2013